Things to Come | GenomeWeb

Things to Come

The next few years may see a number of changes to medicine, but Francis Collins, the director of the US National Institutes of Health, is most excited about the prospect of people being able to have their genomes sequenced at a reasonable cost to inform and tailor their medical care, as he tells USA Today's Brian Gallagher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.